鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/02/04 | 3,195 | 3,255 | 3,195 | 3,215 | +25 | +0.8% | 22,500 |
| 2021/02/03 | 3,210 | 3,220 | 3,185 | 3,190 | -35 | -1.1% | 21,900 |
| 2021/02/02 | 3,240 | 3,280 | 3,205 | 3,225 | -30 | -0.9% | 32,100 |
| 2021/02/01 | 3,230 | 3,305 | 3,230 | 3,255 | +30 | +0.9% | 34,200 |
| 2021/01/29 | 3,275 | 3,320 | 3,225 | 3,225 | -50 | -1.5% | 31,800 |
| 2021/01/28 | 3,235 | 3,285 | 3,215 | 3,275 | ±0 | ±0% | 26,800 |
| 2021/01/27 | 3,215 | 3,290 | 3,210 | 3,275 | +85 | +2.7% | 20,100 |
| 2021/01/26 | 3,240 | 3,240 | 3,190 | 3,190 | -80 | -2.4% | 20,600 |
| 2021/01/25 | 3,260 | 3,280 | 3,245 | 3,270 | +95 | +3% | 23,300 |
| 2021/01/22 | 3,195 | 3,200 | 3,170 | 3,175 | -50 | -1.6% | 25,400 |
| 2021/01/21 | 3,210 | 3,245 | 3,210 | 3,225 | +10 | +0.3% | 14,900 |
| 2021/01/20 | 3,200 | 3,230 | 3,185 | 3,215 | +5 | +0.2% | 13,800 |
| 2021/01/19 | 3,300 | 3,300 | 3,210 | 3,210 | -85 | -2.6% | 21,300 |
| 2021/01/18 | 3,360 | 3,360 | 3,285 | 3,295 | -35 | -1.1% | 14,000 |
| 2021/01/15 | 3,300 | 3,370 | 3,285 | 3,330 | +50 | +1.5% | 38,900 |
| 2021/01/14 | 3,225 | 3,280 | 3,210 | 3,280 | +55 | +1.7% | 22,300 |
| 2021/01/13 | 3,180 | 3,245 | 3,165 | 3,225 | +55 | +1.7% | 34,400 |
| 2021/01/12 | 3,200 | 3,205 | 3,120 | 3,170 | -100 | -3.1% | 44,200 |
| 2021/01/08 | 3,205 | 3,280 | 3,155 | 3,270 | +65 | +2% | 37,500 |
| 2021/01/07 | 3,255 | 3,285 | 3,200 | 3,205 | -25 | -0.8% | 28,000 |
| 2021/01/06 | 3,225 | 3,235 | 3,200 | 3,230 | +10 | +0.3% | 22,600 |
| 2021/01/05 | 3,225 | 3,235 | 3,200 | 3,220 | -5 | -0.2% | 15,500 |
| 2021/01/04 | 3,230 | 3,240 | 3,140 | 3,225 | +5 | +0.2% | 26,500 |
| 2020/12/30 | 3,215 | 3,250 | 3,200 | 3,220 | -20 | -0.6% | 20,000 |
| 2020/12/29 | 3,200 | 3,245 | 3,180 | 3,240 | +25 | +0.8% | 25,100 |
| 2020/12/28 | 3,200 | 3,225 | 3,180 | 3,215 | +15 | +0.5% | 31,600 |
| 2020/12/25 | 3,200 | 3,220 | 3,195 | 3,200 | -20 | -0.6% | 25,200 |
| 2020/12/24 | 3,210 | 3,230 | 3,190 | 3,220 | +15 | +0.5% | 20,600 |
| 2020/12/23 | 3,220 | 3,225 | 3,175 | 3,205 | +10 | +0.3% | 22,500 |
| 2020/12/22 | 3,270 | 3,285 | 3,180 | 3,195 | -55 | -1.7% | 42,300 |
| 2020/12/21 | 3,325 | 3,390 | 3,250 | 3,250 | -100 | -3% | 35,600 |
| 2020/12/18 | 3,220 | 3,385 | 3,220 | 3,350 | -10 | -0.3% | 44,000 |
| 2020/12/17 | 3,360 | 3,395 | 3,350 | 3,360 | +10 | +0.3% | 25,800 |
| 2020/12/16 | 3,390 | 3,395 | 3,350 | 3,350 | +10 | +0.3% | 20,200 |
| 2020/12/15 | 3,360 | 3,405 | 3,340 | 3,340 | -60 | -1.8% | 15,600 |
| 2020/12/14 | 3,330 | 3,415 | 3,315 | 3,400 | +85 | +2.6% | 44,100 |
| 2020/12/11 | 3,310 | 3,340 | 3,295 | 3,315 | -10 | -0.3% | 22,600 |
| 2020/12/10 | 3,265 | 3,350 | 3,250 | 3,325 | +95 | +2.9% | 48,300 |
| 2020/12/09 | 3,230 | 3,265 | 3,215 | 3,230 | +10 | +0.3% | 21,700 |
| 2020/12/08 | 3,200 | 3,235 | 3,170 | 3,220 | +15 | +0.5% | 23,600 |
| 2020/12/07 | 3,280 | 3,295 | 3,200 | 3,205 | -40 | -1.2% | 34,400 |
| 2020/12/04 | 3,255 | 3,325 | 3,220 | 3,245 | -15 | -0.5% | 24,100 |
| 2020/12/03 | 3,240 | 3,290 | 3,215 | 3,260 | +35 | +1.1% | 47,200 |
| 2020/12/02 | 3,210 | 3,270 | 3,205 | 3,225 | +20 | +0.6% | 61,600 |
| 2020/12/01 | 3,185 | 3,245 | 3,175 | 3,205 | +40 | +1.3% | 52,700 |
| 2020/11/30 | 3,220 | 3,250 | 3,155 | 3,165 | -55 | -1.7% | 47,900 |
| 2020/11/27 | 3,200 | 3,235 | 3,180 | 3,220 | +25 | +0.8% | 45,200 |
| 2020/11/26 | 3,205 | 3,235 | 3,180 | 3,195 | +10 | +0.3% | 38,100 |
| 2020/11/25 | 3,205 | 3,220 | 3,150 | 3,185 | -15 | -0.5% | 59,500 |
| 2020/11/24 | 3,250 | 3,260 | 3,180 | 3,200 | -20 | -0.6% | 41,900 |
1051～
1100
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
